Search Results
Results found for "Structure Therapeutics"
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic marker and therapeutic
- Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
Understanding these processes has important implications for understanding the therapeutic intervention
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
binding by searching large-scale motions accompanied with stable maintenance of the fragile cell-membrane structure
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
Furthermore, the formation of GPCRs higher order oligomers provides the structural basis for organizing
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
These therapeutic strategies could greatly impact the treatment of CVD with unprecedented benefits which
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Must-read publications: GPCRs in neurological disorders; OSTα-OSTβ structure; GPCR–G protein–β-arrestin
- Effects of Small Molecule Ligands on ACKR3 Receptors
appreciate the unique roles of ACKR3 in the CXCL12/CXCR4/ACKR3-signaling axis and better understand the structural
- A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation
These findings indicate the potential of inhibiting MC4R homodimerization as a therapeutic target to
- GPCR Signaling and mTORC1 Regulation
of mTOR complex 1 (mTORC1) is typically observed in human disease and continues to be an important therapeutic
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
Currently, there is no cure for RP, and the therapeutic options are limited.
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
consequently activated signaling pathways, and also may shed light on the development of more effective new therapeutics
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
Expectations around intellectual property in biotech fundraising are becoming more structured. This shift is not about stricter rules, but about earlier and clearer risk assessment .
- Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
PTH-related protein (PTHrP) ligands and analogues for their pharmacologic activities and potential therapeutic
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
The bias depends on the agonist’s structure as well as the state of the cannabinoid receptor (whether
- Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet
kinetic studies "G protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
This unpredictability isn’t chaos—it’s structure-driven , and when properly understood, it becomes a
- Canonical chemokine receptors as scavenging “decoys”
The scavenging function of CKRs should be considered when evaluating the safety and therapeutic efficacy
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Our results suggest that strategies to selectively target OGR1 expression may represent a novel therapeutic
- Induced Human Regulatory T Cells Express the Glucagon-like Peptide-1 Receptor
2022 "The glucagon-like peptide-1 receptor (GLP-1R) plays a key role in metabolism and is an important therapeutic
- Precise druggability of the PTH type 1 receptor
PTHR signaling that could be extended to GPCRs to expedite discoveries of small molecules as novel therapeutic
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
Crystal structures suggest ligand access to the orthosteric binding site of MT1 and MT2 receptors through
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Breakthroughs this week: Decoding ADGRE5 signaling; Eli Lilly’s obesity pill vs Novo’s Wegovy; Certa Therapeutics
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
regulating the PI3K/AKT/GSK-3β and MEK/ERK pathways in amygdalae of male mice, implicating a potential, therapeutic
- Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice
2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), is receiving renewed attention for their potential therapeutic
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the...
Our results suggest that GPR15/GPR15L have a pathogenic role in RA and their antagonizing could be a therapeutic
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Pc(4-4) may become a promising candidate for future therapeutic cancer treatment."
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
discrete and separable effects and provide proof of concept for the development of safer GPCR-targeting therapeutics
- G protein-coupled receptors that influence lifespan of human and animal models
substantial participation in a wide variety of processes of human pathophysiology and are one of the main therapeutic
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
and stabilizing IGF1R, and suggests that it may serve as a valuable prognostic factor and potential therapeutic
